Lori Pender Pharmd, Mph, Bcop, Els

Lori Pender, PharmD, MPH, BCOP, ELS has over three decades of experience in the pharmaceutical and healthcare industry. Lori is currently serving as the Director of Scientific & Medical Communications at Lyell Immunopharma, where they oversee the strategic development and execution of medical communications initiatives. Prior to this, they held the position of Associate Director at Lyell Immunopharma.

Before joining Lyell Immunopharma, Lori worked at Adaptive Biotechnologies Corp. as the Director of Medical Affairs, where they played a crucial role in driving the company's medical strategy. Lori also held positions as Associate Director and Senior Manager in the same department.

Lori's experience also includes working at Med-IQ as the Manager of Educational Strategy and Content, where they were responsible for developing and implementing educational programs in the healthcare field. Lori previously served as the Associate Director of Clinical Strategy at Medscape Oncology.

Lori has a strong background in scientific communications consultancy as the founder of CancerScribe Oncology Communications. Lori served as a scientific communications consultant, specializing in oncology, for over 17 years.

Earlier in their career, Lori worked as a Clinical Assistant Professor at the University of Washington School of Pharmacy. Lori has a strong academic background and expertise in pharmacy practice.

Lori has also held various roles at SmithKlineBeecham and Immunex as a Medical Science Liaison and Professional Services Manager, respectively.

Lori began their career as a Clinical Pharmacist at The Johns Hopkins Hospital, where they worked in various departments and was a member of the Pharmacy and Therapeutics Committee.

Overall, Lori Pender has a diverse and extensive background in scientific and medical communications, medical affairs, educational strategy, and pharmacy practice. Lori brings a wealth of knowledge and expertise to their current role at Lyell Immunopharma.

Lori Pender, PharmD, MPH, BCOP, ELS has an extensive education history in the field of pharmacy and clinical trial design and analysis. Lori obtained their Bachelor of Science (BS) degree in Pharmacy from the University of Maryland Baltimore in 1990. Prior to this, they pursued pre-pharmacy coursework at Loyola University Maryland from 1985 to 1987.

In 1995, Lori Pender earned their Master of Public Health (MPH) degree with a concentration in Clinical Trial Design and Analysis from The Johns Hopkins University.

From 2006 to 2011, they attended the University of Washington, where they completed their Doctor of Pharmacy (PharmD) degree.

In addition to their educational achievements, Lori Pender holds certifications that further highlight their expertise. Lori has been a Board Certified Oncology Pharmacist since 2000, certified by the Board of Pharmaceutical Specialties. Additionally, they are an Editor in the Life Sciences, a certification obtained from the Board of Editors in the Life Sciences.

Overall, Lori Pender's education history reflects their commitment to advancing their knowledge and skillset in the fields of pharmacy, clinical trial design and analysis, and oncology.